Bookmark and Share    

Assessing the FDA via the Anomaly of Off-Label Drug Prescribing
By Alexander T. Tabarrok
This article appeared in the Summer 2000 issue of The Independent Review


Abstract

Most American hospital patients are given drugs not approved by the U.S. Food and Drug Administration for the prescribed use. If off-label prescribing is so widespread and successful, is the FDA’s pre-approval process really necessary?



Other Independent Review articles by Alexander T. Tabarrok
    Fall 2013   The Global Organ Shortage: Economic Causes, Human Consequences, Policy Responses
    Spring 2007   The Rise, Fall, and Rise Again of Privateers
    Spring 1999   Privatizing Social Security



Volume 5 Number 1
Summer 2000

Subscribe Today

Buy Single Issues

Independent Review Issues

Articles by Subject

Independent Review Articles on Related Subjects